AMPIN Energy Transition

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

AMPIN Energy Transition secures $195m for 100 MW Andhra Pradesh hybrid project

AMPIN Energy Transition has closed $195 million of long-term financing for a 100 MW PPA-backed solar-wind-storage project, highlighting the capital intensity behind India’s shift from intermittent renewables to dispatchable clean power.

byVenkatesh

August 29, 2026

Aditya Birla Renewables’ ₹17,200 crore acquisition of the Sprng Energy platform from Shell will add around 5 GWp of contracted renewable capacity and significantly expand Grasim Industries’ clean energy footprint. Representative image.

AMPIN Energy secures $195m for 100MW wind-solar-storage project in Andhra Pradesh

AMPIN Energy Transition has secured $195 million of project financing for a 100 MW wind-solar-storage development in Andhra Pradesh designed to deliver renewable power during peak-demand periods.

bySrinath

August 23, 2026

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

AMPIN Energy Transition secures $195m for 100 MW Andhra Pradesh hybrid project

AMPIN Energy secures $195m for 100MW wind-solar-storage project in Andhra Pradesh

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?